Hong Kong (October 12, 2014) – Emerson (NYSE:EMR) today participated in the Heart-to-Heart Charity Walk, organized by the Children’s Heart Foundation (“CHF”), to raise public awareness about congenital heart disease and to promote the importance of exercise on heart health.
Employees from the corporate Asia-Pacific and business units’ offices took part in the charity event, led by Edward L. Monser, president and chief operating officer of Emerson and Sara Yang Bosco, president of Emerson Asia Pacific.
Over 100 employees and their families joined the three-hour CHF annual walkathon at The Peak Galleria. Aside from the walk, the event was also highlighted by an opening performance by congenital heart disease children and variety of game booths and shows. Participants can collect a certificate given by the CHF and gift pack as souvenirs.
This is the first time that Emerson supported the annual walkathon organized by the CHF, as well as the first charitable event participated in Hong Kong for the fiscal year 2015. Through this activity, Emerson donated HK$20,000 to the CHF.
The first CHF Heart-to-Heart Charity Walk took place in 2000. It has since become an annual event, raising more than HK$10 million (approximately US$ 1.3 million) to support the CHF’s charitable services. It aims to raise public awareness about congenital heart disease and to raise funds for the CHF.
With the theme of “pump up to help children with heart disease”, around 5,000 participants attended the walk this year with over HK$1.5 million (approximately US$0.2 million) raised. The event is supported by 25 organizations and sponsored by 10 companies.
Emerson (NYSE: EMR), based in St. Louis, Missouri (USA), is a global leader in bringing technology and engineering together to provide innovative solutions for customers in industrial, commercial, and consumer markets around the world. The company is comprised of five business segments: Process Management, Industrial Automation, Network Power, Climate Technologies, and Commercial & Residential Solutions. Sales in fiscal 2013 were US$24.7 billion. For more information, visit